The regenerative medicine provision plan will be registered with the Ministry of Health, Labor and Welfare after deliberation and approval by the Regenerative Medicine Accreditation Committee.
https://saiseiiryo.mhlw.go.jp/published_plan/index/1/2

Explanations of treatment methods, risks, consent forms, fees, etc. are posted on the Ministry of Health, Labor and Welfare's "Regenerative Medicine Support Site".

The following is an excerpt from the regenerative medicine data we have implemented

Stem cell injection filling therapy for bone resorption dental disease Document 1
Reduced MACCE (Major Adverse Cardiac and Cerebrovascular Events)
Administration of autologous adipose-derived stem cells for the purpose of
Autologous adipose-derived stem cells/stem cell exosome administration therapy for immunosenescence
Treatment with autologous mesenchymal stem cell transplantation for osteoarthritis Document 1 Document 2
Cultivation of mesenchymal stem cells isolated from autologous skin and subcutaneous tissue and subcutaneous administration to the face Document 1 Document 2
Cultivation of mesenchymal stem cells isolated from autologous skin and subcutaneous tissue and external administration to the face Document 1 Document 2
Scalp injection therapy of autologous adipose-derived mesenchymal stem cells for hair loss Document 1 Document 2
Intravenous administration of autologous adipose-derived mesenchymal stem cells (containing MSC exosomes) for type 2 diabetes Document 1
×
×
×
×
×
×
×
×
×
×
×
×

×

×
×

×
×
×
×
×

×
×
×
×
culture video
×
×
Former Health, Labor and Welfare Minister Ritsuo Hosokawa
×

×

×
×
×
×
×